Back to top
more

CSL Limited (CSLLY)

(Delayed Data from OTC)

$90.10 USD

90.10
108

-0.61 (-0.67%)

Updated Apr 24, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CSLLY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for CSL Limited Sponsored ADR falls in the month of June.

All items in Millions except Per Share data.

6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Assets          
Cash & Equivalents 1,557 10,441 1,814 1,198 658
Receivables 2,236 1,687 1,796 1,739 1,843
Notes Receivable 0 0 0 0 0
Inventories 5,466 4,333 3,781 3,510 3,039
Other Current Assets 0 0 0 0 0
Total Current Assets 9,259 16,461 7,390 6,446 5,540
Net Property & Equipment 7,797 7,017 6,434 5,366 4,484
Investments & Advances 173 403 22 14 10
Other Non-Current Assets 96 13 7 14 22
Deferred Charges 902 518 530 543 379
Intangibles 16,446 2,638 2,670 2,140 1,878
Deposits & Other Assets 6 5 4 1 2
Total Assets 36,234 28,346 18,157 15,465 12,314
Liabilities & Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2,947 2,301 2,040 1,525 1,408
Current Portion Long-Term Debt 1,055 4,494 474 202 421
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 296 132 313 254 162
Other Current Liabilities 310 182 277 160 198
Total Current Liabilities 4,608 7,108 3,104 2,142 2,188
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,464 670 497 392 203
Convertible Debt 0 0 0 0 0
Long-Term Debt 11,172 5,164 5,333 5,791 4,242
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,164 826 842 613 429
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 18,408 13,769 9,776 8,937 7,063
Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 517 484 -4,505 -4,561 -4,603
Capital Surplus 0 0 0 0 0
Retained Earnings 14,621 13,503 12,253 10,752 9,612
Other Equity 2,688 590 633 336 242
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 17,826 14,578 8,381 6,528 5,251
Total Liabilities & Shareholder's Equity 36,234 28,346 18,157 15,465 12,314
Total Common Equity 17,826 14,578 8,381 6,528 5,251
Shares Outstanding 964.70 963.40 910.20 908.10 905.90
Book Value Per Share 18.48 15.13 9.21 7.19 5.80

Fiscal Year End for CSL Limited Sponsored ADR falls in the month of June.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,999 -99,999 1,557 -99,999
Receivables NA NA NA 2,236 NA
Notes Receivable NA NA NA 0 NA
Inventories NA NA NA 5,466 NA
Other Current Assets NA NA NA 0 NA
Total Current Assets NA NA NA 9,259 NA
Net Property & Equipment NA NA NA 7,797 NA
Investments & Advances NA NA NA 173 NA
Other Non-Current Assets NA NA NA 96 NA
Deferred Charges NA NA NA 902 NA
Intangibles NA NA NA 16,446 NA
Deposits & Other Assets NA NA NA 6 NA
Total Assets NA NA NA 36,234 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA NA 0 NA
Accounts Payable NA NA NA 2,947 NA
Current Portion Long-Term Debt NA NA NA 1,055 NA
Current Portion Capital Leases NA NA NA 0 NA
Accrued Expenses NA NA NA 0 NA
Income Taxes Payable NA NA NA 296 NA
Other Current Liabilities NA NA NA 310 NA
Total Current Liabilities NA NA NA 4,608 NA
Mortgages NA NA NA 0 NA
Deferred Taxes/Income NA NA NA 1,464 NA
Convertible Debt NA NA NA 0 NA
Long-Term Debt NA NA NA 11,172 NA
Non-Current Capital Leases NA NA NA 0 NA
Other Non-Current Liabilities NA NA 1,164 NA
Minority Interest (Liabilities) NA NA NA 0 NA
Total Liabilities NA NA NA 18,408 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA NA 0 NA
Common Stock (Par) NA NA NA 517 NA
Capital Surplus NA NA NA 0 NA
Retained Earnings NA NA NA 14,621 NA
Other Equity NA NA NA 2,688 NA
Treasury Stock NA NA NA 0 NA
Total Shareholder's Equity NA NA NA 17,826 NA
Total Liabilities & Shareholder's Equity NA NA NA 36,234 NA
Total Common Equity 0 0 0 17,826 0
Shares Outstanding 966.50 966.10 966.10 964.70 964.70
Book Value Per Share 0.00 0.00 0.00 18.48 0.00